Anti-hyperalgesic effects of the novel metabotropic glutamate receptor 5 antagonist, 2-methyl-6-(phenylethynyl)-pyridine, in rat models of inflammatory pain

被引：0
|
作者：
Bowes, M
Panesar, M
Gentry, C
Urban, L
Gasparini, F
Kuhn, R
Walker, K
机构：
[1] Novartis Pharma AG, Basel, Switzerland
[2] Novartis Inst Med Sci, London WC1E 6BN, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1999年 / 126卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
250P
引用
收藏
页码：U130 / U130
页数：1
相关论文
共 50 条
  • [21] Anticonvulsant activity of two metabotropic glutamate Group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893)
    Chapman, AG
    Nanan, K
    Williams, M
    Meldrum, BS
    NEUROPHARMACOLOGY, 2000, 39 (09) : 1567 - 1574
  • [22] Discovery of 2-methyl-6-(phenylethynyl)-pyridine (MPEP): A highly potent and selective mGluR5 antagonist
    Gasparini, F
    Lingenhoehl, K
    Flor, PJ
    Stoehr, N
    Stierlin, C
    Heinrich, M
    Vranesic, I
    Allgeier, H
    Biollaz, M
    Heckendorn, R
    Urwyler, S
    Schmutz, M
    Spooren, W
    Varney, MA
    Johnson, EC
    Hess, SD
    Sakaan, A
    Santori, E
    Velicelebi, G
    Kuhn, R
    NEUROPHARMACOLOGY, 1999, 38 (10) : A16 - A17
  • [23] Anti-hyperalgesic effects of imidazoline I2 receptor ligands in a rat model of inflammatory pain: interactions with oxycodone
    Thorn, David A.
    Siemian, Justin N.
    Zhang, Yanan
    Li, Jun-Xu
    PSYCHOPHARMACOLOGY, 2015, 232 (18) : 3309 - 3318
  • [24] Anti-hyperalgesic effects of imidazoline I2 receptor ligands in a rat model of inflammatory pain: interactions with oxycodone
    David A. Thorn
    Justin N. Siemian
    Yanan Zhang
    Jun-Xu Li
    Psychopharmacology, 2015, 232 : 3309 - 3318
  • [25] Activation of spinal group I metabotropic glutamate receptors in rats evokes local glutamate release and spontaneous nociceptive behaviors: effects of 2-methyl-6-(phenylethynyl)-pyridine pretreatment
    Lorrain, DS
    Correa, L
    Anderson, J
    Varney, M
    NEUROSCIENCE LETTERS, 2002, 327 (03) : 198 - 202
  • [26] The mGlu5 receptor antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) supports intravenous self-administration and induces conditioned place preference in the rat
    van der Kam, Elizabeth L.
    De Vry, Jean
    Tzschentke, Thomas M.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 607 (1-3) : 114 - 120
  • [27] The effects of α2-adrenoceptor agents on anti-hyperalgesic effects of carbamazepine and oxcarbazepine in a rat model of inflammatory pain
    Vuckovic, Sonja M.
    Tomic, Maja A.
    Stepanovic-Petrovic, Radica M.
    Ugresic, Nenad
    Prostran, Milica S.
    Boskovic, Bogdan
    PAIN, 2006, 125 (1-2) : 10 - 19
  • [28] Two-methyl-6-phenylethynyl-pyridine (MPEP), a metabotropic glutamate receptor 5 antagonist, with low doses of MK801 and diazepam: A novel approach for controlling status epilepticus
    Tang, Feng Ru
    Chen, Peng Min
    Tang, Yong Cheng
    Tsai, Mui Chiung
    Lee, Wei Ling
    NEUROPHARMACOLOGY, 2007, 53 (07) : 821 - 831
  • [29] Effects of the prototypical mGlu5 receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine on rotarod, locomotor activity and rotational responses in unilateral 6-OHDA-lesioned rats
    Spooren, WPJM
    Gasparini, F
    Bergmann, R
    Kuhn, R
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 406 (03) : 403 - 410
  • [30] 2-methyl-6-(phenylethynyl)-pyridine (MPEP), a novel potent non-competitive mGluR5 antagonist, acts at a site in the transmembrane region
    Pagano, A
    Rüegg, D
    Litschig, S
    Stoehr, N
    Stierlin, C
    Vranesic, I
    Heinrich, M
    Flor, PJ
    Gasparini, F
    Kuhn, R
    NEUROPHARMACOLOGY, 1999, 38 (10) : A33 - A34
12345